In patients receiving end-of-life care, medications used to treat co-morbid diseases should be discontinued when appropriate
Crossref DOI link: https://doi.org/10.1007/s40267-014-0153-1
Published Online: 2014-08-16
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Text and Data Mining valid from 2014-08-16